Amid rising global cases and threatening variants, a major gap remains to be filled in the world’s strategy for defeating the pandemic: effective therapeutics. Now, a Massachusetts startup powered by a wide range of HPC resources – including hometown resources from the Massachusetts Green High Performance Computing Center (MGHPCC) – has identified four promising FDA-approved drugs whose efficacy as COVID-19 therapeutics is supported by data from millions of patients.
Read the story at HPC Wire
Biotech Firm Identifies Four Drugs that Could be Used Against COVID-19 - COVID-19 HPC Consortium Press Release
Checking the Medicine Cabinet to Interrupt Covid-19 at the Molecular Level - MGHPCC News
